Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
33 /100
MEDIUM RISK
Score updated Oct 13, 2026

WVE — Wave Life Sciences Ltd. Dilution Risk Tracker

Track WVE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track WVE — Get alerts when the score changes →

As of October 13, 2026, Wave Life Sciences Ltd. (WVE) has a DilutionWatch DilutionScore of 33/100, rated MEDIUM dilution risk. Wave Life Sciences Ltd. has a market capitalization of $646.32M, 197.05M shares outstanding, 237 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
0
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for WVE.
🔔 Track WVE — Get forecast alerts →

Market Data

Market Cap$646.32M
Shares Outstanding197.05M
Float90.11M
Cash$393.05M
Debt$15.71M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore33/100DilutionWatch score record
Shares Outstanding197.05MVerified float table or market cache
Public Float90.11MVerified float table or market cache
Market Cap$646.32MMarket data cache
Cash Runway66.9 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 3 2, 4 3, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 1.8% shares (2026Q1 vs prior)
237 institutional holders · 185.49M shares
#1 RA CAPITAL MANAGEMENT, L.P. 26.98M shares
#2 GSK plc 18.25M shares
#3 BlackRock, Inc. 14.12M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest18.56M
Days to Cover5.7
% of Float20.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-02-26
xbrl XBRL CONVERTIBLE 2018-03-12
3 FORM3 2026-04-17
3 FORM3 2026-04-17
4 INSIDER TRANSACTION 2026-03-30
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual WVE Dilution Snapshot

Wave Life Sciences Ltd. (WVE) has a DilutionScore of 33/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

WVE's DilutionScore is currently 33/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 30/100 (Medium risk).

Period Score Risk Level Duration
Aug 14 – Oct 13, 202633/100MEDIUM60 days
Jul 16 – Aug 13, 202630/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

WVE shares outstanding have increased 3.6% from 185.76M (Mar 2026) to 192.40M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 19, 2026192.40M90.11M▼ 10.13%
May 17, 2026192.40M100.27M▲ 10.83%
May 10, 2026192.40M90.47M▼ 28.77%
Apr 30, 2026192.38M127.01M▲ 2.19%
Apr 27, 2026188.25M124.28M▲ 0.09%
Apr 24, 2026188.25M124.17M▲ 1.14%
Apr 20, 2026188.25M122.77M▼ 0.11%
Apr 11, 2026188.25M122.91M▲ 1.49%
Apr 03, 2026188.25M121.10M▼ 6.75%
Mar 06, 2026188.25M129.88M▲ 21.77%
Mar 05, 2026185.76M106.66M▲ 18.66%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track WVE Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment WVE files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking WVE — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for WVE
WVE FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.